Dr Maciej Kawecki: Immunoterapia zmienia rokowania w raku jelita grubego

Immunotherapy isn't for everyone with colorectal cancer, but in patients with microsatellite instability, it can completely change the course of the disease. Dr. Maciej Kawecki from the Department of Oncology and Radiotherapy at the Maria Skłodowska-Curie National Institute of Oncology – National Research Institute discusses how to recognize early symptoms, why biomarkers are important, and what the July reimbursement of dual immunotherapy means.